Reimbursement models that align primary care with behavioral health offer low-income provider organizations serving rural Americans and other vulnerable populations an opportunity to enhance coordination and improve outcomes while generating sorely needed revenue. The post How to Align Primary Care With Behavioral Health appeared first on MedCity News.
Kidney stones are a widespread occurrence in today’s day and age. As a general trend, the incidence is especially higher in women and men in the middle age group. Most of the time, kidney stones are tiny and pass through undetected. Sometimes, they are large enough to cause an obstruction in the urinary tract and…
It’s winter across the northern hemisphere, the flu season is officially in full swing, and a new virus is shining more than the others. The HPMV, or human metapneumovirus, is creating an outbreak in China. More than 200 affected people and hospitals flooded with patients; China is grappling with yet another health crisis, and the threat of…
Maven Clinic’s $125 million Series F funding round was led by StepStone Group and included participation from existing investors General Catalyst, Sequoia, Oak HC/FT, Icon Ventures, Dragoneer Investment Group and Lux Capital. The post Maven Clinic Snags $125M To Boost Fertility Program, Expand Value-Based Care Partnerships appeared first on MedCity News.
Now is the time for health plans to step up and embrace the tools and strategies that will not only meet regulatory demands, but also drive innovation in care delivery. The post Where Medicare Advantage Goes From Here appeared first on MedCity News.
When Preston Nafz was 12, he asked his dad for permission to play lacrosse. “First practice, he came back, he said, ‘Dad, I love it,’” recalled his father, Lothar Nafz, of Hoover, Alabama. “He lives for lacrosse.” But years of youth sports took a toll on Preston’s body. By the time the teenager limped off…
By MIKE MAGEE The leaders of America’s scientific community seem genuinely surprised by the actions of the past three weeks. They expected to be spared the wrath of Trump because they believed that “Americans of all political persuasions have respect for science and celebrate its breakthroughs.” Maybe so. But that is an inadequate defense against a…
BenevolentAI said it will still develop its internally discovered drugs, but will now seek partners for them earlier in their development. Going forward, BenevolentAI will focus on making its AI technologies available to support the drug R&D efforts of its partners. The post AI Biotech BenevolentAI Restructures Again, This Time to Return to Its TechBio…
This volume covers recent claims about COVID vaccine safety after a new study describes a rare condition it calls “post-vaccination syndrome” (PVS). It also investigates the false claim that ivermectin can treat cancer and highlights the re-emergence of concerns online about Gardasil, and its alleged mortality rate.
Hospital CEO David Berger, M.D., says tools such as ‘Ask Avo’ could transform how clinicians access evidence at the bedside